Tag Archives: Head and Neck Squamous Cell Carcinoma

Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

Katelyn D. Bothwell1,2, Margaret Folaron1,3, and Mukund Seshadri1,3,4. Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer. Cancers. January 7th, 2016. Full Text – Open Access Publication Date January 2016 How Analyze was Used “To quantify tumor necrosis, captured fit images were uploaded into Analyze software and specified regions of interest…

Image-guided interstitial photodynamic therapy for squamous cell carcinomas: preclinical investigation

Sajisevi M, Rigual NR, Bellnier DA, Seshadri M. Image-guided interstitial photodynamic therapy for squamous cell carcinomas: preclinical investigation. J Oral Maxillofac Surg Med Pathol. April 2014. Publication Date April 2014 How Analyze was Used “T2 maps and apparent diffusion coefficient (ADC) maps were generated on a pixel-by-pixel basis…and pseudo-colorized for visualization using Analyze (AnalyzeDirect, Overland…

Vascular priming enhances chemotherapeutic efficacy against head and neck cancer

Folaron M, Kalmuk J, Lockwood J, Frangou C, Vokes J, Turowski SG, Merzianu M, Rigual NR, Sullivan-Nasca M, Kuriakose MA, Hicks WL, Jr., Singh AK, Seshadri M. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol. September 2013;49(9):893-902. Full Text – Open Access Publication Date September 2013 How Analyze was Used “All…